WeChat Mini Program
Old Version Features

Impact of Time to Metastasis (synchronous Vs. Metachronous) on Outcomes in Metastatic Renal Cell Carcinoma Patients Treated with First Line Immune-Checkpoint Inhibitors (Ici)-Based Combinations

Georges Gebrael,Luis Meza,Xiaochen Li,Zeynep Zengin,Nicolas Sayegh,Hedyeh Ebrahimi,Nishita Tripathi,Daniela Castro,Benjamin Mercier,Regina Barragan-Carrillo,Haoran Li,Alexander Chehrazi-Raffle,Umang Swami,Abhishek Tripathi,Neeraj Agarwal,Benjamin L. Maughan,Sumanta K. Pal

EUROPEAN UROLOGY FOCUS（2024）

Cited 0|Views55
Key words
Immune checkpoint inhibitors,Metastatic renal cell carcinoma,Metachronous,Synchronous,Survival outcomes
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined